Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › East Liverpool › NPI 1659375673
Hospital

The City Hospital Association

The City Hospital Association was paid $16.46M by Medicaid between Jan 2018 and Dec 2024, across 216 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoTHE CITY HOSPITAL ASSOCIATION
EAST LIVERPOOL, OH 43920
33aNPI1659375673assigned 06/08/2005
28Total paid$16.46M
24GClaims491,743
24DCodes billed216
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#56 of 101
Median peer was paid$22.32M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201851,284$1.68M
201954,076$1.36M
202046,795$1.92M
202155,830$1.92M
202260,981$1.98M
2023121,784$4.14M
2024incomplete100,993$3.46M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 23,658 21,897 $2.89M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 22,657 20,808 $2.73M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 14,858 13,346 $2.05M
96361 Intravenous infusion, hydration; each additional hour 6.5% 3,232 2,746 $1.07M
80053 Comprehensive metabolic panel 4.9% 48,257 39,275 $802K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.7% 5,788 5,292 $777K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.5% 9,024 2,253 $580K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.3% 6,677 2,062 $538K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.9% 5,688 1,654 $482K
70450 Computed tomography, head or brain; without contrast material 2.2% 1,330 1,181 $356K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.9% 1,089 952 $309K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 48,407 38,400 $286K
204 more codes
41899 Unlisted procedure, dentoalveolar structures 1.4% 200 $236K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.1% 6,256 $181K
84443 Thyroid stimulating hormone (TSH) 1.0% 8,774 $171K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 555 $164K
80061 Lipid panel <1% 10,395 $144K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,181 $142K
36415 Collection of venous blood by venipuncture <1% 60,554 $136K
82607 <1% 3,914 $104K
71046 Radiologic examination, chest; 2 views <1% 2,964 $101K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 760 $95K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,425 $90K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 705 $86K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,221 $82K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 582 $74K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 526 $73K
83036 Hemoglobin; glycosylated (A1C) <1% 4,871 $70K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 526 $63K
81001 <1% 16,799 $59K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,068 $53K
97161 <1% 561 $50K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 192 $50K
85027 <1% 4,736 $49K
82728 <1% 2,051 $48K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,634 $42K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 297 $40K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 801 $40K
84439 <1% 1,882 $38K
80048 Basic metabolic panel (calcium, ionized) <1% 3,395 $38K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,866 $38K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,293 $36K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,603 $29K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 14 $26K
87070 <1% 1,221 $26K
87088 <1% 7,878 $26K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,755 $24K
97164 <1% 432 $24K
83605 <1% 6,150 $24K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 6,462 $23K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,425 $22K
83550 <1% 1,923 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 890 $21K
84484 <1% 4,972 $20K
82977 <1% 1,344 $20K
82746 <1% 1,656 $20K
97165 <1% 153 $19K
83735 <1% 9,351 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,874 $18K
83540 <1% 1,931 $18K
99406 <1% 601 $17K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 168 $17K
71045 Radiologic examination, chest; single view <1% 6,706 $17K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 686 $15K
86140 <1% 4,391 $15K
77063 Screening digital breast tomosynthesis, bilateral <1% 293 $14K
92523 <1% 180 $14K
73030 <1% 486 $14K
74018 <1% 466 $13K
73130 <1% 557 $12K
99214 Doctor's office visit, returning patient (more involved) <1% 105 $12K
85610 <1% 4,693 $12K
80320 <1% 907 $12K
84436 <1% 727 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 88 $11K
G0378 Hospital observation service, per hour <1% 218 $10K
87077 <1% 1,447 $10K
86617 <1% 493 $10K
84479 <1% 711 $10K
73630 <1% 579 $9K
93971 <1% 92 $9K
85046 <1% 1,219 $8K
97113 <1% 99 $8K
84481 <1% 637 $8K
86003 <1% 179 $8K
99215 Doctor's office visit, returning patient (complex) <1% 76 $8K
73562 <1% 335 $7K
76770 <1% 47 $7K
87186 <1% 1,597 $7K
76830 Ultrasound, transvaginal <1% 57 $7K
73610 <1% 514 $7K
73110 <1% 146 $7K
88142 <1% 373 $7K
72100 <1% 305 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 288 $7K
80074 <1% 303 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,905 $6K
72110 <1% 87 $6K
73502 <1% 191 $6K
85651 <1% 1,201 $6K
86225 <1% 303 $6K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 108 $6K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 91 $6K
97014 <1% 154 $6K
83690 <1% 5,703 $5K
71250 <1% 55 $5K
82785 <1% 179 $5K
84153 <1% 282 $5K
97162 <1% 62 $5K
82570 <1% 473 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 2,688 $5K
86431 <1% 425 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 409 $5K
80076 <1% 349 $4K
84550 <1% 561 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,650 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 380 $4K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 20 $4K
82043 <1% 535 $4K
86038 <1% 424 $4K
12002 <1% 25 $4K
12001 <1% 28 $4K
82140 <1% 278 $4K
70486 <1% 48 $4K
92522 <1% 41 $4K
87481 <1% 103 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 293 $3K
84100 <1% 528 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 158 $3K
84702 <1% 881 $3K
85730 <1% 3,893 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 18 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 147 $3K
87040 <1% 1,674 $3K
87420 <1% 575 $3K
83970 <1% 82 $2K
82550 <1% 886 $2K
97168 <1% 28 $2K
87205 <1% 463 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 95 $2K
97016 <1% 77 $2K
73560 <1% 27 $2K
86618 <1% 48 $2K
90715 <1% 142 $2K
87081 <1% 1,099 $1K
87510 <1% 46 $1K
83880 <1% 715 $1K
87075 <1% 186 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,237 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 16 $988.17
87480 <1% 46 $950.42
81025 <1% 1,388 $927.33
82248 <1% 112 $914.65
72072 <1% 15 $897.72
73080 <1% 50 $872.85
00170 Anesthesia for intraoral procedures, including biopsy <1% 281 $837.54
87625 <1% 12 $804.41
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,082 $769.49
85007 <1% 633 $740.84
86850 <1% 43 $721.04
86328 <1% 21 $696.93
86900 <1% 43 $643.61
J3490 Unclassified drugs <1% 145 $608.07
87660 <1% 46 $601.68
80164 <1% 52 $582.38
73564 <1% 15 $572.46
80069 <1% 30 $529.61
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 267 $478.20
86762 <1% 31 $461.03
86592 <1% 80 $455.13
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 134 $436.43
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 872 $372.60
80329 <1% 467 $371.10
80177 <1% 29 $363.20
86901 <1% 43 $351.48
96376 <1% 132 $350.92
84460 <1% 30 $345.76
87147 <1% 30 $290.45
84703 <1% 72 $265.24
84156 <1% 49 $255.02
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 769 $249.73
82947 <1% 19 $248.76
84134 <1% 33 $239.53
J2270 Injection, morphine sulfate, up to 10 mg <1% 314 $238.56
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,034 $173.39
86308 <1% 41 $164.26
84402 <1% 12 $162.85
84146 <1% 14 $150.47
82565 <1% 12 $144.09
86703 <1% 14 $132.55
85379 <1% 127 $106.11
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,000 $105.35
J1170 Injection, hydromorphone, up to 4 mg <1% 190 $103.92
88304 <1% 43 $82.22
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 828 $79.21
70320 <1% 85 $79.03
88300 <1% 53 $66.36
J7120 Ringers lactate infusion, up to 1000 cc <1% 948 $55.24
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 511 $52.16
J2704 Injection, propofol, 10 mg <1% 1,074 $35.30
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 325 $27.16
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 579 $24.95
J3010 Injection, fentanyl citrate, 0.1 mg <1% 758 $23.17
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 270 $14.19
86701 <1% 33 $13.10
86702 <1% 33 $13.10
J1815 Injection, insulin, per 5 units <1% 16 $9.45
J2060 Injection, lorazepam, 2 mg <1% 35 $3.62
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 273 $2.34
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 47 $1.31
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 94 $0.61
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 258 $0.19
J0690 Injection, cefazolin sodium, 500 mg 0% 25 $0.00
94760 0% 70 $0.00
94761 0% 18 $0.00
00126 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Same official

Other billing entities under DOAN, CHRISTOPHER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.